EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 105 filers reported holding EPIZYME INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $1,460,000 | +2079.1% | 116,300 | +962.1% | 0.00% | – |
| Q4 2018 | $67,000 | -42.2% | 10,950 | +0.3% | 0.00% | – |
| Q3 2018 | $116,000 | -22.1% | 10,920 | -0.5% | 0.00% | – |
| Q2 2018 | $149,000 | -24.0% | 10,980 | -1.0% | 0.00% | – |
| Q1 2018 | $196,000 | +19500.0% | 11,090 | +31585.7% | 0.00% | – |
| Q3 2014 | $1,000 | -50.0% | 35 | -36.4% | 0.00% | – |
| Q2 2014 | $2,000 | -86.7% | 55 | -85.1% | 0.00% | – |
| Q3 2013 | $15,000 | +50.0% | 369 | 0.0% | 0.00% | – |
| Q2 2013 | $10,000 | – | 369 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 9,166,667 | $109,358,000 | 16.39% |
| Burrage Capital Management LLC | 1,002,528 | $11,960,000 | 9.44% |
| Foresite Capital Management III, LLC | 998,278 | $11,909,000 | 8.87% |
| MPM BioImpact LLC | 2,854,737 | $34,057,000 | 8.20% |
| Palo Alto Investors LP | 6,403,600 | $76,395,000 | 4.19% |
| Foresite Capital Management II, LLC | 862,402 | $10,288,000 | 2.24% |
| Redmile Group, LLC | 8,311,633 | $99,158,000 | 1.82% |
| Pier Capital, LLC | 574,299 | $6,851,000 | 1.00% |
| Foresite Capital Management I, LLC | 243,759 | $2,908,000 | 0.82% |
| Rock Springs Capital Management LP | 2,551,659 | $30,441,000 | 0.77% |